In Depth 31 Mar 2023
How has the collapse of the Silicon Valley Bank affected the biotech industry?
When investors got wind of Silicon Valley Bank (SVB) being forced to sell its treasury bonds at a loss, owing…
Collaboration deals
- Latest Posts
Opinion 24 Mar 2023
PAN-TB regimens to address growing TB drug resistance
By Dr. Charles Wells, head of therapeutics development at Gates Medical Research Institute As nearly one-quarter of the world’s population…
News and Trends 23 Mar 2023
OncoC4 and BioNTech partner in the commercialization of cancer drug candidate
German biopharma BioNTech has closed a licensing deal with the U.S.-based clinical-stage company OncoC4 for the development and commercialization of…
Expert Advice 14 Mar 2023
5 reasons why collaboration is important in research
In the life sciences industry, collaboration is paramount in the field of research, to help move ideas and programs forward…
ADVERTISEMENT
News and Trends 13 Mar 2023
Sanofi adds diabetes drug through Provention Bio $2.9B acquisition
Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type…
News and Trends 8 Mar 2023
Affibody and Chiesi Group to develop treatments for respiratory diseases
Affibody AB and Chiesi Farmaceutici S.p.A have announced a collaboration and licensing agreement to develop and commercialize innovative treatments for…
News and Trends 3 Mar 2023
Lilly to develop Confo pain drug
Confo Therapeutics, which works on the discovery of medicines targeting G-protein coupled receptors (GPCRs), has announced a worldwide licensing agreement…
News and Trends 3 Mar 2023
Porton and DanausGT look to boost development of gene and cell therapy
Porton Advanced Solutions Ltd. and DanausGT Biotechnology Co., Ltd. have announced a strategic collaboration in gene and cell therapy pipelines…
News and Trends 2 Mar 2023
Partnership formed to develop miRNA to treat pancreatic cancer
RNA delivery and therapeutics company SiSaf Ltd is to collaborate with the University of Leipzig in Germany to develop targeted…
News and Trends 28 Feb 2023
Peter MacCallum Cancer Centre and Cartherics to work on CAR-T cell therapy for ovarian cancer
Peter MacCallum Cancer Centre (Peter Mac) in Australia and Cartherics Pty Ltd have entered into a collaborative development program agreement…
ADVERTISEMENT
Sponsored by Kadans Science Partner
28 Feb 2023How open ecosystems encourage knowledge sharing and accelerate scientific innovation
Human societies today are based around knowledge economies, where knowledge is currency and where quick, innovative solutions for problems are…
News and Trends 23 Feb 2023
Moderna and Life Edit Therapeutics look to speed up gene editing therapies
Moderna, Inc., a biotechnology company working on messenger RNA (mRNA) therapeutics and vaccines, and Life Edit Therapeutics Inc., an ElevateBio…
News and Trends 14 Feb 2023
Scancell looking to partner after positive COVID vaccine data
Scancell Holdings plc, which develops novel immunotherapies for the treatment of cancer and infectious disease, has announced preliminary immunogenicity data…
News and Trends 14 Feb 2023
Syena created to deliver first-in-class TCR-NK cell therapy
Replay, a genome writing company reprogramming biology by writing and delivering big DNA, and The University of Texas MD Anderson…
News and Trends 14 Feb 2023
Astex and Cardiff University Medicines Discovery Institute to collaborate on neurodegenerative diseases
Astex Pharmaceuticals (UK), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and…
News and Trends 10 Feb 2023
Heartseed and Novo Nordisk dose first patient in heart failure cell therapy study
Heartseed Inc. and Novo Nordisk A/S say Heartseed has successfully dosed the first patient in a phase 1/2 clinical study…
ADVERTISEMENT
News and Trends 7 Feb 2023
Mnemo Therapeutics and Institut Curie studies lead to cancer-specific targets
Mnemo Therapeutics, a French biotechnology company developing immunotherapies, has announced publication of two scientific studies developed at Institut Curie, its…
News and Trends 2 Feb 2023
Orbit Discovery and Endevica Bio to develop cachexia therapeutics
Orbit Discovery Limited has entered into a multi target research agreement with Endevica Bio Inc. Endevica creates first-in-class therapeutics for…
News and Trends 2 Feb 2023
AstraZeneca creates FRAGLER for DNA synthesis
“Plasmids are critical for so many processes in early drug discovery,” says David Öling, associate principal scientist at AstraZeneca. “From…
Interview 1 Feb 2023
Foundation for the National Institutes of Health: partnering to tackle cancer
The Foundation for the National Institutes of Health (FNIH) takes on cancer through public-private research partnerships on prevention and early…
